Table 1 Characteristics of Population
Author | Year | Region | Age | eye | Mydriasis | Type of study | Device | Outcome measures | Study Quality |
|---|---|---|---|---|---|---|---|---|---|
Oner V [11] | 2013 | Turkey | 5 ~ 16 | 94 | Yes | cross-sectional | Cirrus HD SD-OCT | pRNFL | 7 |
Chang, Xuejia [12] | 2022 | China | 6 ~ 12 | 43 | yes | cross-sectional | SS-OCT/OCTA | SFCT,ChT | 6 |
Ji FT [13] | 2022 | China | 3～18 | 53 | Yes | cross-sectional | IOL Master;SD-OCT | AL,CR,CT | 6 |
Ya Shi [14] | 2021 | China | 19.73 ± 2.18 | 230 | Yes | cross-sectional | Optical low-coherence reflectometry (Aladdin; Topcon, Japan) | AL,ACD,CCT,LT,GCC | 7 |
Xiaoyan Bian [15] | 2021 | China | 11～18 | 444 | N/A | cross-sectional | IOL Master | AL,CC | 6 |
Bueno-Gimeno, Inmaculada [16] | 2018 | Spain | 6～17 | 199 | Yes | cross-sectional | IOLMaster;VisanteOCT; Cirrus HD-OCT | AL,CCT,RNFL | 8 |
Sun, Yunyun [17] | 2021 | China | 20 ± 1.4 | 7650 | Yes | cross-sectional | Lenstar LS900 | AL,CR,AL/CR,CCT, LT,ACD | 9 |
Yi Zha [18] | 2018 | China | 6～12 | 154 | No | cross-sectional | IOL Master; SD-OCT | AL,ChT,SFCT,RT | 6 |
Sheng Ye [19] | 2019 | China | 6～15 | 482 | Yes | cross-sectional | Lenstar LS900 | AL,AL/CR,CCR,ACD, LT,CCT | 8 |
Li,L [20] | 2018 | China | 3～18 | 66,071 | No | cross-sectional | IOL Master | AL | 7 |
Bayrakceken K [21] | 2023 | Turkey | 12～18 | 68 | Yes | case-control | Nidek AL-Scan; OCTA Nidek’s RS300 | AL,ChT,GCC | 6 |
Kristian Lundberg [22] | 2018 | Denmark | 14～17 | 307 | N/A | cross-sectional | Lenstar LS900;SD-OCT | AL,ChT | 7 |
Ashutosh Jnawalia [23] | 2020 | America | 6～15 | 53 | Yes | cross-sectional | Lenstar LS900;SD-OCT | AL,CR,ACD,LT, pNRFL,RT | 8 |
Bulut, Asker [24] | 2016 | Turkey | 5～17 | 117 | Yes | cross-sectional | Lenstar LS900;Cirrus HD-OCT | AL,ChT | 6 |
Cui, Dongmei [25] | 2021 | China | 24.03 ± 1.95 | 92 | Yes | case-control | IOL Master | AL | 5 |
Jan Willem Lodewijk Tideman [26] | 2018 | Netherlands | 9 | 2408 | Yes | cohort design | LenStar device | AL,AL/CR,CR | 7 |
Xiangui He [27] | 2015 | China | 6～12 | 3922 | Yes | cross-sectional | IOL Master | AL,AL/CR,CR | 8 |
Yulin Tao [28] | 2022 | China | 1～21 | 494 | Yes | cross-sectional | NIDEK CO LTD AL-Scan | AL,CC,ACD,CCT | 6 |
Shuyu Xiong [29] | 2017 | China | 6～19 | 3001 | Yes | cross-sectional | IOL Master | AL | 7 |
Wen Long, MD [30] | 2019 | China | 4～6 | 216 | Yes | cross-sectional | IOL Master | AL,CC,ACD,CCT | 5 |
Tideman,W [31] | 2017 | Netherlands | 6～9 | 2408 | Yes | cross-sectional | LenStar device | AL,AL/CR | 7 |
Li,Yan [32] | 2022 | China | 6～12 | 4806 | Yes | cohort design | IOL Master | AL,AL/CR,CR,ACD | 6 |
Shi-Ming Li [33] | 2016 | China | 14 | 1890 | Yes | cross-sectional | LenStar device | AL,ACD,LT | 7 |
Li-Li Lu [34] | 2022 | China | 8～12 | 418 | N/A | case-control | IOL Master | AL,CC,CCT | 7 |
Dogan,Mehmethan [35] | 2019 | Turkey | 6～16 | 150 | Yes | cross-sectional | LenStar LS900 | AL,CC,ACD,CCT,LT | 5 |
Dayi,O [36] | 2022 | Turkey | 3～14 | 344 | Yes | cross-sectional | NIDEK CO LTD AL-Scan | AL,AL/CR,CR,ACD | 4 |
PEIYAO JIN [37] | 2016 | China | 7～13 | 276 | Yes | cross-sectional | IOLMaster;SS-OCT | SFCT,ChT | 7 |
Geun Young Lee [38] | 2017 | Korea | 6～12 | 89 | Yes | cross-sectional | IOL Master;Spectralis OCT | AL,ChT | 6 |
Veysel Aykut [39] | 2013 | Turkey | 5～15 | 120 | N/A | cross-sectional | IOLMaster;Optovue OCT | pRNFL,AL | 5 |
Herrera, Laura [40] | 2015 | Spain | 4～16 | 93 | Yes | cross-sectional | IOL Master; Spectralis OCT | AL,SFCT | 7 |
Liang Lv [41] | 2022 | China | 7～13 | 71 | Yes | cross-sectional | IOL Master; Spectralis OCT | RT,AL,VD | 6 |
Lee,Jacky W.Y. [42] | 2015 | Hong Kong, China | 4～18 | 201 | Yes | cross-sectional | IOL Master; Heidelberg SD-OCT | pRNFL,AL | 8 |
Xiang,Z [43] | 2021 | China | 3～12 | 131 | Yes | cross-sectional | IOL master | AL,CC,CCT,ACD,LT | 7 |
zhao zhi [44] | 2018 | China | 6～12 | 1091 | Yes | cross-sectional | IOL master | AL,CC,AL/CR,CR | 9 |
Jiangnan He [45] | 2019 | China | 17～23 | 760 | N/A | cross-sectional | Topcon Aladdin;SS-OCT | AL,ACD,LT,CCT | 8 |
Xiaolei Wang [46] | 2021 | China | 15～17 | 78 | N/A | case-control | RTVue-XR OCT | pRNFL,AL | 7 |
Li, Junmeng [47] | 2021 | China | 8～16 | 86 | Yes | case-control | IOL Master | AL | 5 |
Guan,X.H [48] | 2020 | China | 12～18 | 145 | Yes | cross-sectional | IOL Master | AL | 6 |
Lin,TaiNan [49] | 2021 | China | 6～17 | 204 | N/A | cross-sectional;case-control | IOL Master;Cirrus HD-OCT | pRNFL,AL | 8 |
Liu,Y.T. [50] | 2021 | China | 6～18 | 230 | Yes | cross-sectional | IOL Master;RTVue-XR OCT | RT,AL,VD | 5 |
Inmaculada Bueno-Gimeno [51] | 2017 | Spain | 6～17 | 199 | Yes | cross-sectional | IOL Master;Cirrus HD-OCT | RT,AL,pRNFL | 8 |
Jingfeng Mu [52] | 2022 | China | 8～18 | 300 | Yes | cross-sectional | IOL Master | AL,AL/CR | 7 |
Li,K.R [53] | 2019 | China | 3～16 | 605 | Yes | cross-sectional | IOL Master | AL,CR,AL/CR | 8 |
Qian,Yu [54] | 2021 | China | 4～10 | 106 | N/A | case-control | IOL Master;SS-OCT | AL | 5 |
Wenner,Yaroslava [55] | 2018 | Germany | 6～15 | 63 | Yes | cross-sectional | IOL Master; HRT II (Heidelberg) | pRNFL/AL | 7 |
Sasaki,Kozue [56] | 2022 | Japan | 6～12 | 60 | Yes | case-control | IOL Master;OCTA | RT,AL | 5 |
Wan-Peng Wang [57] | 2013 | China | 5～12 | 1626 | N/A | cross-sectional | IOL Master | AL,CC,ACD | 5 |
Duan,Fang [58] | 2019 | China | 17～23 | 87 | Yes | cross-sectional | Lenstar LS900 | AL,ACD | 6 |
Gupta,Preeti [59] | 2015 | Singapore | 17～22 | 648 | Yes | case-control | IOL Master | AL,CR,ACD | 8 |
Gupta,Preeti [60] | 2017 | Singapore | 18～22 | 603 | Yes | cross-sectional | IOL Master | AL/CR | 8 |
Lu Xiaoli [61] | 2022 | China | 5～18 | 90 | N/A | cross-sectional | Lenstar LS900 | CC | 7 |
Ya Zhang [62] | 2021 | China | 3～6 | 8801 | N/A | cross-sectional | IOL Master | AL/CR | 6 |
Hashemi, Hassan [63] | 2022 | Iran | 6～12 | 4731 | Yes | cross-sectional | Lenstar LS900 | ACD | 7 |
Wang,Jing [64] | 2018 | China | 6～18 | 1321 | Yes | cross-sectional | FD-OCT | ACD | 6 |
Junjie Deng [65] | 2018 | China | 9～16 | 340 | Yes | cross-sectional | IOL Master;SS-OCT | ChT | 6 |
Li,Shufeng [66] | 2021 | China | 9～13 | 58 | N/A | cohort design | SS-OCT | ChT,VD | 7 |
Liu,Wei-Qin [67] | 2019 | China | 6～10 | 260 | N/A | cross-sectional | HD-OCT | ChT | 7 |
Chun On Lee [68] | 2021 | Hong Kong, China | 6～8 | 114 | Yes | cohort design | SD-OCT | ChT,RT | 6 |
Jyoti Matalia [69] | 2018 | India | 5～17 | 113 | Yes | cross-sectional | RTVue-XR OCT | ChT,RT | 8 |
Tao Li [70] | 2016 | China | 7～15 | 193 | Yes | cross-sectional | Cirrus HD-OCT | ChT,RT | 6 |
Xia ZheRen [71] | 2013 | China | 5～14 | 129 | N/A | case-control | Heidelberg SD-OCT | ChT,pRNFL | 7 |
Gordon S.K.Yau [72] | 2015 | China | 4～18 | 168 | Yes | cross-sectional | Heidelberg SD-OCT | RT | 6 |
Qin Zhu [73] | 2021 | China | 14～18 | 95 | N/A | cross-sectional | IOL Master; RTVue-XR OCTA | RT,AL,ACD,LT,VD | 8 |
Deng,Junjie [74] | 2018 | China | 8～15 | 2964 | Yes | cross-sectional | IOL Master; SS-OCT | RT,GCC | 7 |
Yi Zha [75] | 2017 | China | 18 ± 7.95 | 271 |  N/A | cross-sectional | Heidelberg SD-OCT | pRNFL | 6 |
Guo,H.M. [76] | 2015 | China | 8～17 | 165 | Yes | case-control | Cirrus HD OCT | pRNFL | 6 |
Meng-Tian Kang MD [77] | 2016 | China | 7 | 1811 | Yes | cross-sectional | iVue-100 OCT | pRNFL | 8 |
Xiaolei Wang [78] | 2021 | China | 7 | 2505 | Yes | cross-sectional | iVue-100 OCT | pRNFL,GCL | 8 |
Othman, S. F. [79] | 2012 | Malaysia | 19～24 | 63 | Yes | cross-sectional | Stratus OCT 3000 | RT | 6 |